SRC and ovarian carcinoma: The deterioration of the G2 arrest under the hypoxic environment of 1% O2 has also been validated in SKOV3 human ovarian cancer cells following treatment with Paclitaxel, postulating the inhibition of the Src/Stat3/HIF-1α pathway as a potential mechanism [76].